HK Stock Market Move | LIFETECH SCI (01302) is now up more than 4%. G-iliacPro iliac artery stent system has received official registration approval from the drug regulatory agency.

LIFETECH SCI (01302) is now up over 4%, as of the time of writing, it has risen by 4.43% to 1.65 Hong Kong dollars, with a trading volume of 43.5211 million Hong Kong dollars. In terms of news, LIFETECH SCI announced that on January 7, 2026, the company's independently developed G-iliacPro iliac artery coverage stent system (G-iliacPro) received official registration approval from the China National Drug Administration. The announcement stated that this product is suitable for intraluminal treatment of abdominal aortic aneurysm combined with iliac artery aneurysm or isolated iliac artery aneurysm, reconstructing the internal iliac artery to ensure pelvic blood supply, providing a more mature and complete solution for clinical use, and systematically upgrading existing treatment options.